Flushing ports of totally implantable venous access devices, and impact of the Huber point needle bevel orientation: Experimental tests and numerical computation

Medical Devices: Evidence and Research

Volumn 5, Issue 1, 2012, Pages 31-37

  Guiffant, Gérard ^a   Durussel, Jean Jacques ^a   Flaud, Patrice ^a   Vigier, Jean Pierre ^a   Merckx, Jacques ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Fushing; Implantable ports; Obstruction; Prevention; Totally implantable venous access devices (TIVADS)

Indexed keywords

ACCESS DEVICES; FUSHING; IMPLANTABLE PORTS; OBSTRUCTION; PREVENTION;

NEEDLES;

ANALYTICAL PARAMETERS; ARTICLE; CONTROLLED STUDY; DYNAMICS; EXPERIMENTAL TEST; FLOW KINETICS; HUBER POINT NEEDLE; IMPLANT; MATHEMATICAL ANALYSIS; NEEDLE; QUANTITATIVE STUDY; STATISTICAL ANALYSIS; TOTALLY IMPLANTABLE VENOUS ACCESS DEVICE; VASCULAR ACCESS; VASCULAR ACCESS DEVICE;

EID: 84860811359     PISSN: None     EISSN: 11791470     Source Type: Journal    
DOI: 10.2147/mder.s30029     Document Type: Article

References (19)

1. Adlera A, Yanivb I, Steinbergc R, et al. Infectious complications of implantable ports and Hickman catheters in paediatric haematology- oncology patients. J Hosp Infect. 2006;62(3):358-365.
2. Ahmadi J, Izadyar M, Ashjaei B, et al. Study of advantages and disadvantages of totally implanted venous access device. Acta Med Iran. 2006;44(3):199-202.
3. Hall P, Cedermark B, Swedenborg J. Implantable catheter system for long-term intravenous chemotherapy. J Surg Oncol. 1989;41(1): 39-41.
4. Herrmann KA, Waggershauser T, Sittek H, Reiser MF. Liver intraarte-rial chemotherapy: use of the femoral artery for percutaneous implantation of catheter-port systems. Radiology. 2000;215(1):294-299.
5. Hirota T, Yamagami T, Tanaka O, et al. Brain infarction after percutaneous implantation of port-catheter system via the left subclavian artery. Br J Radiol. 2002;75(898):799-804.
6. Yamagami T, Kato T, Iida S, Hirota T, Nishimura T. Management of end hole in placement of port-catheter system for continuous hepatic arterial infusion chemotherapy using the fxed catheter tip method. Am J Roentgenol. 2005;184(4):1332-1339
7. Yamagami T, Terayama K, Yoshimatsu R, Matsumoto T, Miura H, Nishimura T. Use of N-butyl cyanoacrylate in implantation of a port-catheter system for hepatic arterial infusion chemotherapy with the fxed-catheter-tip method: is it necessary? Am J Roentgenol. 2008; 191(5):1523-1529.
8. MALER G. Sécurité des dispositifs médicaux et utilisation des cham-bres à cathéters implantables et des aiguilles. ANAES Lettre Circulaire. DGS/EM 1. No 96-6225. 28 octobre 1996.
9. MALER G. Evaluation de la qualité de l'utilisation et de la surveillance des chambres à cathéters implantables. ANAES Lettre Circulaire. DGS/ DH No 98-249. 20 avril 1998.
10. Baskin JL, Pui CH, Reiss U, et al. Management of occlusion and thrombosis associated with long term indwelling central venous catheters. Lancet. 2009;374(9684):159-169.
11. Pittiruti M, Hamilton H, Biff R, MacFie J, Pertkiewicz M. ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications). Clin Nutr. 2009;28(4): 365-377.
12. Ragni M V, Journeycake JM, Brambilla DJ. Tissue plasminogen activator to prevent central venous access device infections: a systematic review of central venous access catheter thrombosis, infection, and thrombo-prophylaxis. Haemophilia. 2008;14(1):30-38.
13. Guiffant G, Durussel JJ, Merckx J, Flaud P, Vigier J-P, Mousset P. Flushing of intravascular access devices (IVADs) Efficacy of pulsed and continuous infusions. J Vasc Access. July 11, 2011. [Epub ahead of print.]
14. Vigier J P, Merckx J, Coquin JY, Flaud P, Guiffant G. The use of a hydro-dynamic bench for experimental simulation of fushing venous catheters: impact of the technique. ITBM-RBM Innovation et Technologie en Biologie Medicine-Revue de Tech Biomediale. 2005;26(2): 147-149.
15. Chevallier P, Haïdopoulos M, Mantovani D. Biomatériaux: implantation d'une prothèse artérielle synthétique. Le médecin du Québec. 2003;38(6):115-123.
16. Drumheller PD. Materials and methods for the immobilization of bioac-tive species onto polymeric substrates. United States Patent 5897955. April 27, 1999.
17. Horbett TA. The role of adsorbed proteins in animal cell adhesion. Colloids Surf B Biointerfaces. 1994;2(1-3):225-240.
18. Pellenc D, Berry H, Gallet O. Adsorption-induced fibronectin aggregation and fibrillogenesis. J Colloid Interface Sci. 2006; 298(1):132-144.
19. Potts JR, Campbell ID. Fibronectin structure and assembly. Curr Opin Cell Biol. 1994;6(5):648-655.